MarketInOut Stock Screener Log In | Sign Up

Tissue Repair Ltd

Healthcare • Biotechnology • Quote as of 10/29/2026 12:51
Tissue Repair Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
Market Capitalization5.44 mln
Float55.57 mln
Earnings Date03/04/2027

Piotroski F-Score

3 / 9
Below average

Relative Strength

93 / 100
Top performer

Pre-Tax Margin

-1,392%
Severely loss-making

ROE

-46.60
Deeply negative

Altman Z-Score

-3.36
Deeply distressed

ROA

-43.06
Deeply negative

Business Description

Tissue Repair Ltd is an Australian company focused on developing new treatments that help wounds heal faster and more effectively. Founded in 2012 and headquartered in Chatswood, the company uses its proprietary Glucoprime technology to activate the body's immune system and support skin recovery. Its two main products are TR-987, a topical treatment currently in late-stage clinical trials for chronic wounds and venous leg ulcers, and TR Pro+, a gel designed to aid recovery after cosmetic and medical procedures.

Key Fundamentals

EPS-0.09
ROE-46.60
RPS0.05
ROIC-174
ROA-43.06
EBITDA, mln-7.57
EV / EBITDA-0.05
EV / EBIT-0.05
Revenue, mln0.56
EV / Revenue0.66

Quote Details

Last 0.095
Change 0.005 (5.56%)
Open 0.095
Volume 16,648
Turnover 1,581.56
Average Volume 59,317

Financial Ratios

Pre-Tax Profit Margin-1,392
Leverage Ratio1.18
Current Ratio6.36
Price / Book0.59
Price / Tangible Book0.57
Price / Sales9.44

Financial Strength

Altman Z-Score-3.36
Piotroski F-Score 3 / 9

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 14.46% 97 / 100   
1 Month 15.85% 97 / 100   
2 Months -9.52% 33 / 100   
6 Months -42.42% 13 / 100   
1 Year -66.67% 6 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog